S-Bank Fund Management Ltd

Bank

Position in INCY — Incyte Corp

CIK 2036461 HELSINKI, H9

Position in INCY

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$358,104

+$178,986 QoQ

Shares Held

3,159

+49.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#584

of 854 holders

Holding Since

Mar 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

S-Bank Fund Management Ltd holds $2,967,528 across 5 Biotechnology names. INCY ranks #5 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,034	$1,010,348
2	REGN	Regeneron Pharmaceuticals, Inc.	1,012	$631,022
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,844	$555,099
4	RPRX	Royalty Pharma plc	7,365	$412,955
5	INCY	Incyte Corp This page	3,159	$358,104

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$358,104	3,159	+49.6%	Shares	Sole	2026-08-04
2025-09-30	$179,118	2,112	-1.3%	Shares	Sole	2025-10-27
2025-06-30	$145,734	2,140	-4.5%	Shares	Sole	2025-07-29
2025-03-31	$135,632	2,240	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.